Context Therapeutics Inc
Context Therapeutics Inc. is a biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors. The company is focused on developing innovative therapies, including CTIM-76 and CT-202, to improve treatment outcomes for cancer patients.